Concepedia

Publication | Open Access

Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis

DOIFull Paper Access

41

Citations

7

References

2013

Year

Partha Roy, Shiji John, Sadashiv Karankal, Sadhana Kannan, Preeti Pawaskar, Jayanta Gawande, Bhausaheb Bagal, Navin Khattry, Manju Sengar, Hari Menon,
Indian Journal of Medical and Paediatric Oncology

Abstract

We observed no significant differences in the toxicity, tumor response rates, PFS and OS between the two available brands of rituximab.

References

YearCitations

Page 1